169 related articles for article (PubMed ID: 37186040)
21. Two and five-factor models of negative symptoms in schizophrenia are differentially associated with trait affect, defeatist performance beliefs, and psychosocial functioning.
Paul NB; Strauss GP; Gates-Woodyatt JJ; Barchard KA; Allen DN
Eur Arch Psychiatry Clin Neurosci; 2023 Dec; 273(8):1715-1724. PubMed ID: 36633673
[TBL] [Abstract][Full Text] [Related]
22. Development and Validation of a Computerized Adaptive Assessment Tool for Discrimination and Measurement of Psychotic Symptoms.
Guinart D; de Filippis R; Rosson S; Patil B; Prizgint L; Talasazan N; Meltzer H; Kane JM; Gibbons RD
Schizophr Bull; 2021 Apr; 47(3):644-652. PubMed ID: 33164091
[TBL] [Abstract][Full Text] [Related]
23. Reliability and validity of the Calgary Depression Scale for Schizophrenia (CDSS) in youth at clinical high risk for psychosis.
Addington J; Shah H; Liu L; Addington D
Schizophr Res; 2014 Mar; 153(1-3):64-7. PubMed ID: 24439270
[TBL] [Abstract][Full Text] [Related]
24. The impact of the COVID-19 pandemic on negative symptoms in individuals at clinical high-risk for psychosis and outpatients with chronic schizophrenia.
Strauss GP; Macdonald KI; Ruiz I; Raugh IM; Bartolomeo LA; James SH
Eur Arch Psychiatry Clin Neurosci; 2022 Feb; 272(1):17-27. PubMed ID: 33881621
[TBL] [Abstract][Full Text] [Related]
25. Preliminary psychometric properties of the brief Negative Symptom Scale in youth at Clinical High-Risk for psychosis.
Strauss GP; Chapman HC
Schizophr Res; 2018 Mar; 193():435-437. PubMed ID: 28779853
[TBL] [Abstract][Full Text] [Related]
26. Reprint of: A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis.
Strauss GP; Pelletier-Baldelli A; Visser KF; Walker EF; Mittal VA
Schizophr Res; 2021 Jan; 227():63-71. PubMed ID: 33526203
[TBL] [Abstract][Full Text] [Related]
27. Validation of a European Spanish-version of the Self-Evaluation of Negative Symptoms (SNS) in patients with schizophrenia.
García-Álvarez L; Martínez-Cao C; Bobes-Bascarán T; Portilla A; Courtet P; de la Fuente-Tomás L; Velasco Á; González-Blanco L; Zurrón-Madera P; Fonseca-Pedrero E; Sáiz PA; García-Portilla MP; Bobes J
Rev Psiquiatr Salud Ment (Engl Ed); 2022; 15(1):14-21. PubMed ID: 35256068
[TBL] [Abstract][Full Text] [Related]
28. Symptom assessment in early psychosis: the use of well-established rating scales in clinical high-risk and recent-onset populations.
Fulford D; Pearson R; Stuart BK; Fisher M; Mathalon DH; Vinogradov S; Loewy RL
Psychiatry Res; 2014 Dec; 220(3):1077-83. PubMed ID: 25278477
[TBL] [Abstract][Full Text] [Related]
29. Detection of early psychotic symptoms: Validation of the Spanish version of the "Symptom Onset in Schizophrenia (SOS) inventory".
Mezquida G; Cabrera B; Martínez-Arán A; Vieta E; Bernardo M
Psychiatry Res; 2018 Mar; 261():68-72. PubMed ID: 29287238
[TBL] [Abstract][Full Text] [Related]
30. The Brief Negative Symptom Scale (BNSS): Independent validation in a large sample of Italian patients with schizophrenia.
Mucci A; Galderisi S; Merlotti E; Rossi A; Rocca P; Bucci P; Piegari G; Chieffi M; Vignapiano A; Maj M;
Eur Psychiatry; 2015 Jul; 30(5):641-7. PubMed ID: 25758156
[TBL] [Abstract][Full Text] [Related]
31. Validation of the German version of the Clinical Assessment Interview for Negative Symptoms (CAINS).
Engel M; Fritzsche A; Lincoln TM
Psychiatry Res; 2014 Dec; 220(1-2):659-63. PubMed ID: 25138895
[TBL] [Abstract][Full Text] [Related]
32. Assessing negative symptoms in schizophrenia: Validity of the clinical assessment interview for negative symptoms in Singapore.
Rekhi G; Ang MS; Yuen CKY; Ng WY; Lee J
Schizophr Res; 2019 Apr; 206():177-182. PubMed ID: 30558979
[TBL] [Abstract][Full Text] [Related]
33. Polish version of the Self-evaluation of Negative Symptoms (SNS).
Wójciak P; Górna K; Domowicz K; Jaracz K; Szpalik R; Michalak M; Rybakowski J
Psychiatr Pol; 2019 Jun; 53(3):551-559. PubMed ID: 31522196
[TBL] [Abstract][Full Text] [Related]
34. Using the Beck Depression Inventory to Assess Anhedonia: A Scale Validation Study.
Cogan AB; Persons JB; Kring AM
Assessment; 2024 Mar; 31(2):431-443. PubMed ID: 37039528
[TBL] [Abstract][Full Text] [Related]
35. Bipolar Prodrome Symptom Scale - Abbreviated Screen for Patients: Description and validation.
Van Meter A; Guinart D; Bashir A; Sareen A; Cornblatt BA; Auther A; Carrión RE; Carbon M; Jiménez-Fernández S; Vernal DL; Walitza S; Gerstenberg M; Saba R; Cascio NL; Correll CU
J Affect Disord; 2019 Apr; 249():357-365. PubMed ID: 30807937
[TBL] [Abstract][Full Text] [Related]
36. Motivation and Pleasure Scale-Self-Report (MAP-SR): Validation of the German version of a self-report measure for screening negative symptoms in schizophrenia.
Engel M; Lincoln TM
Compr Psychiatry; 2016 Feb; 65():110-5. PubMed ID: 26773998
[TBL] [Abstract][Full Text] [Related]
37. The Italian version of the 92-item Prodromal Questionnaire: Concurrent validity with the SIPS and factor analysis in a sample of 258 outpatients aged 11-36years.
Kotzalidis GD; Solfanelli A; Piacentino D; Savoja V; Fiori Nastro P; Curto M; Lindau JF; Masillo A; Brandizzi M; Fagioli F; Raballo A; Gebhardt E; Preti A; D'Alema M; Fucci MR; Miletto R; Andropoli D; Leccisi D; Girardi P; Loewy RL; Schultze-Lutter F
Schizophr Res; 2017 Nov; 189():50-56. PubMed ID: 28254200
[TBL] [Abstract][Full Text] [Related]
38. Psychometric evaluation of the Temporal Experience of Pleasure Scale (TEPS) in a German sample.
Simon JJ; Zimmermann J; Cordeiro SA; Marée I; Gard DE; Friederich HC; Weisbrod M; Kaiser S
Psychiatry Res; 2018 Feb; 260():138-143. PubMed ID: 29195165
[TBL] [Abstract][Full Text] [Related]
39. The Yoruba version of the Beck Hopelessness Scale: psychometric characteristics and correlates of hopelessness in a sample of Nigerian psychiatric outpatients.
Aloba O; Akinsulore A; Mapayi B; Oloniniyi I; Mosaku K; Alimi T; Esan O
Compr Psychiatry; 2015 Jan; 56():258-71. PubMed ID: 25446724
[TBL] [Abstract][Full Text] [Related]
40. Measuring common responses to psychosis: Assessing the psychometric properties of a new measure.
Tully S; Wells A; Pyle M; Hudson J; Gumley A; Kingdon D; Schwannauer M; Turkington D; Morrison AP
Schizophr Res; 2017 Mar; 181():131-136. PubMed ID: 27746054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
